Skip to main content

Innovent Biologics Inc

IVBXF
Exchange
OTC
SEC CIK
0001774163

No open-market purchases or sales by Innovent Biologics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding IVBXF, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding IVBXF at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Innovent Biologics Inc insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Innovent Biologics Inc insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Innovent Biologics Inc at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding IVBXF in 13F filings for Q2 2026.